staceywhite, Author at European Medical Journal - Page 49 of 195

Latest Spring Journal Out Now!

Explore this new issue showcasing multidisciplinary healthcare and other pertinent topics, including contraceptive use among females with…

Non-Factor Therapies in Current Clinical Practice

The 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) took place on 6th–9th February 2024 in…

Sparsentan for treatment of immunoglobulin A nephropathy: Latest study results

In patients with immunoglobulin A nephropathy, use of the endothelin 1 Type A/Ang II subtype 1 receptor antagonist sparsentan can decrease proteinuria and preserve kidney function

Transitioning Patients From Second- to First-Line Prophylaxis in Hereditary Angioedema

Targetted prophylaxis is recommended for people with HAE, but many remain on attenuated androgens. EMJ spoke to two HAE experts who explain how they help patients to make the switch.

Interview: Emer Kelly

Emer Kelly. Respiratory Consultant and General Physician, St. Vincent’s University Hospital, Dublin, Ireland. I had asthma as a child, so…

Interview: Kiley Whalen

Kiley Whalen. Physician Assistant, Adirondack Rehabilitation Medicine; Master of Science in Physician Assistant Studies at the Center for…

Reviewing Advances in Bone Health

The Bone Health Forum is a sponsored standalone event that unites top experts from the JAPAC region.

Interview: Anil Dhawan

Anil Dhawan – Professor of Paediatric Hepatology, King’s College London, UK. I started in paediatric hepatology in 1992, when I got a…

Precision Medicine in Lung Cancer Treatment

Nathan Merrill, University of Michigan, Ann Arbor, USA, presents his work on a precision medicine-based platform, which is used to…

Interview: Smeeta Sinha

Smeeta Sinha National Clinical Director for Renal Medicine, NHS England, UK; Consultant Nephrologist, Northern Care Alliance NHS Foundation…